Camlin Fine Sciences Ltd. (BSE: 532834) is a Mumbai, Maharashtra-based company in the Aroma Chemicals industry. With a market capitalisation of ₹1,539 Cr, it ranks #1,376 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 10 in Aroma Chemicals. At ₹76.88 (as of 16 Nov 2026), the share price is 60.0% below its 52-week high of ₹192.00 and 5.0% above its 52-week low of ₹73.25. The share price is down 59.4% over one year and down 27.8% over three months.
| Current Price | ₹76.88 |
|---|---|
| Market Cap | ₹1,539 Cr |
| BSE Code | 532834 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Aroma Chemicals |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -3.36% |
| Return on Assets | 1.07% |
| 52-Week Range | ₹73.25 – ₹192.00 |
| 1-Year Price Change | -59.4% |
| 3-Month Price Change | -27.8% |
| Beta (1Y) | 0.59 |
| Dividend Yield | 0.00% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.camlinfs.com |
| Revenue | ₹491 Cr |
|---|---|
| Net Profit | ₹-30 Cr |
| Net Margin | -6.0% |
| EPS (Basic) | ₹-1.39 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Camlin Fine Sciences Ltd. reported revenue of ₹491 Cr in Q2 FY27, up 6.9% from ₹460 Cr in Q2 FY26 and down 5.5% from ₹520 Cr in Q1 FY27. It posted a net loss of ₹30 Cr for the quarter, against a net loss of ₹15 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹424 Cr (Q1 FY26) to ₹520 Cr (Q1 FY27). The company reported a net loss in 5 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹491 Cr | −₹30 Cr | −6.0% |
| Q1 FY27 | ₹520 Cr | −₹34 Cr | −6.5% |
| Q4 FY26 | ₹425 Cr | ₹86 Cr | 20.3% |
| Q3 FY26 | ₹457 Cr | −₹37 Cr | −8.1% |
| Q2 FY26 | ₹460 Cr | −₹15 Cr | −3.3% |
| Q1 FY26 | ₹424 Cr | −₹11 Cr | −2.5% |
| Q4 FY25 | ₹437 Cr | ₹0 Cr | 0.0% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 48.03% of Camlin Fine Sciences Ltd.'s shares as of Sept 2026, unchanged from Nov 2025. Delivery averaged 44.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its prodycrts under the Xtendra, Nasure, Ezential, adorr, Dinamic, and Biosus brands. The company’s products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agr
1. Fine Chemicals-This segment researches, develops, manufactures, and markets specialty chemicals, ingredients, and additive blends.
1. Speciality Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Privi Speciality Chemicals Ltd | ₹13,399 Cr | 40.9 | 24.76% | ₹760 Cr | +3.0% |
| Vinati Organics Ltd | ₹11,786 Cr | 26.5 | 14.90% | ₹680 Cr | -31.9% |
| Clean Science & Technology Ltd | ₹7,500 Cr | 32.5 | 15.31% | ₹299 Cr | -22.8% |
| S H Kelkar And Company Ltd | ₹1,832 Cr | 26.3 | 5.25% | ₹636 Cr | -40.2% |
| Oriental Aromatics Ltd | ₹1,643 Cr | 497 | 0.50% | ₹318 Cr | +36.5% |
| Camlin Fine Sciences Ltd. | ₹1,539 Cr | n/m | -3.36% | ₹491 Cr | -59.4% |
| Gem Aromatics Limited | ₹745 Cr | 531.5 | 0.32% | ₹104 Cr | -30.9% |
| Ambica Agarbathies Aroma & Indus | ₹42 Cr | 11.3 | 3.11% | ₹40 Cr | -9.5% |
| VIKRAM AROMA LIMITED | ₹32 Cr | — | — | — | +27.6% |
Listed by market capitalisation. Ratios are shown for context only.
Camlin Fine Sciences Ltd. is trading at ₹76.88, with a market capitalisation of ₹1,539 Cr.
Camlin Fine Sciences Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Aroma Chemicals).
Camlin Fine Sciences Ltd. has a return on equity of -3.36%.
Camlin Fine Sciences Ltd. is listed on the BSE under the scrip code 532834.
Camlin Fine Sciences Ltd.'s share price is down 59.4% over one year and down 27.8% over three months. Its 52-week range is ₹73.25 to ₹192.00.
In Q2 FY27, Camlin Fine Sciences Ltd. reported revenue of ₹491 Cr and net profit of ₹-30 Cr, with basic EPS of ₹-1.39 (consolidated, parsed from the company's exchange filing).
Camlin Fine Sciences Ltd. reported revenue of ₹491 Cr in Q2 FY27, up 6.9% from ₹460 Cr in Q2 FY26 and down 5.5% from ₹520 Cr in Q1 FY27.
Promoters held 48.03% of Camlin Fine Sciences Ltd.'s shares as of Sept 2026, unchanged from Nov 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.